Skip to main content

Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer

  • The original article was published in World Journal of Surgical Oncology 2015 13:195

Retraction note: World J Surg Oncol

https://doi.org/10.1186/s12957-015-0607-5

The Editor-in-Chief is retracting this article [1] due to overlap with the following articles (amongst others) [2,3,4,5,6].

None of the authors have responded to any correspondence from the Editor-in-Chief or publisher about this retraction.

References

  1. 1.

    Kai Y, Qiang C, Xinxin P, Miaomiao Z, Kuailu L. Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Oncol. 2015;13:195.

    Article  Google Scholar 

  2. 2.

    Zhu, et al. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients. Diagn Pathol. 2014;(9):198 http://diagnosticpathology.biomedcentral.com/articles/10.1186/s13000-014-0198-4.

  3. 3.

    Fo, et al. MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. OncoTargets and Therapy. 2014;7 https://www.dovepress.com/front_end/mir-206-functions-as-a-tumor-suppressor-and-directly-targets-k-ras-in%2D%2Dpeer-reviewed-article-OTT.

  4. 4.

    Tang M, et al. MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. OncoTargets Therapy. 2013;6:833–8 https://www.dovepress.com/microrna-145-downregulation-associates-with-advanced-tumor-progression-peer-reviewed-article-OTT.

    CAS  PubMed  Google Scholar 

  5. 5.

    Ye, et al. miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal Cancer. Plos One. 2013. https://journals.plos.org/plosone/article?id. https://doi.org/10.1371/journal.pone.0060687.

    CAS  Article  Google Scholar 

  6. 6.

    Sun, et al. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma. Biomed Pharmacother. 2015;71:58–63 http://www.sciencedirect.com/science/article/pii/S0753332215000633?np=y&npKey=36a5e61c240440f5c791ebb330c69e53b99cf4b599d8cf35805ed8498bb593a4.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Lin Kuailu.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kai, Y., Qiang, C., Xinxin, P. et al. Retraction Note: Decreased miR-154 expression and its clinical significance in human colorectal cancer. World J Surg Onc 17, 105 (2019). https://doi.org/10.1186/s12957-019-1647-z

Download citation